Presentations at eado highlight potential impact of castle biosciences' decisiondx®-melanoma and decisiondx®-scc tests on the management of patients with skin cancer

Friendswood, texas--(business wire)---- $cstl #cstl--castle will share new data on its decisiondx-melanoma and decisiondx-scc tests at the 20th european association of dermato-oncology (eado) congress.

CSTL Ratings Summary

CSTL Quant Ranking